Human milk vacuolating cytotoxin A immunoglobulin A antibodies modify Helicobacter pylori infection in Gambian children

Clinical Infectious Diseases

Volumn 43, Issue 8, 2006, Pages 1040-1042

  Campbell, D I ^a   Bunn, J E G ^e,f   Weaver, L T ^d   Harding, M ^b   Coward, W A ^c   Thomas, J E ^a,g  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^e MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^f LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^g ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; UNCLASSIFIED DRUG; VACUOLATING TOXIN; VACUOLATING TOXIN ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL COLONIZATION; BODY WEIGHT; BREAST MILK; FEMALE; GAMBIA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; UREA BREATH TEST; WEIGHT REDUCTION;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; GAMBIA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFANT; INFANT, NEWBORN; MILK, HUMAN;

EID: 33750307296     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/507524     Document Type: Article

References (17)

1. Thomas JE, Bunn JEG, Kleanthous H, et al. Specific immunoglobulin A antibodies in maternal milk and delayed Helicobacter pylori colonization in Gambian infants. Clin Infect Dis 2004; 39:1155-60.
2. Thomas JE, Dale A, Bunn JEG, et al Early Helicobacter pylori colonisation: the association with growth faltering in The Gambia. Arch Dis Child 2004; 89:1149-54.
3. Dale A, Thomas JE, Darboe MK, Coward WA, Harding M, Weaver LT. Helicobacter pylori infection, gastric acid secretion and infant growth. J Pediatr Gastroenterol Nutr 1998; 26:393-7.
4. Guarino A, Bisceglia M, Canani RB, et al. Enterotoxic effect of the vacuolating toxin produced by Helicobacter pylori in Caco-2 cells. J Infect Dis 1998; 178:1373-8.
5. Pelicic V, Reyrat JM, Sartori L, et al. Helicobacter pylori VacA cytotoxin associated with the bacteria increases epithelial permeability independant of its vacuolating activity. Microbiology 1999; 145:2043-50.
6. Li Y, Wandinger-Ness A, Goldenring JR, Cover TL. Clustering and redistribution of late endocytic compartments in response to Helicobacter pylori vacuolating toxin. Mol Biol Cell 2004; 15:1946-59.
7. Atherton JC. CagA: a role at last. Gut 2000; 47:330-1.
8. Puls J, Fischer W, Haas R. Activation of Helicobacter pylori CagA by tyrosine phosphorylation is essential for dephosphorylation of host cell proteins in gastric epithelial cells. Mol Microbiol 2002; 43:961-9.
9. Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295:683-6.
10. Thomas JE, Dale A, Harding M, et al. Interpreting the 13-C urea breath test in early life in early childhood. Pediatr Res 1999; 46:147-51.
11. Pagliaccia C, Wang XM, Tardy F, Telford JL, Ruysschaert JM, Cabiaux V. Structure and interaction of VacA of Helicobacter pylori with a lipid membrane. Eur J Biochem 2000; 267:104-9.
12. Ilver D, Barone S, Mercati D, Lupetti P, Telford JL. Helicobacter pylori toxin VacA is transferred to host cells via a novel contact-dependent mechanism. Cell Microbiol 2004; 6:167-74.
13. Thomas JE, Whatmore AM, Barer MB, Eastham EJ, Kehoe MA. Serodiagnosis of Helicobacter pylori infection in childhood. J Clin Microbiol 1990; 28:2641-6.
14. Arthur HML, Bunn JEG, Thomas JE, Weaver LT. Human milk immunoglobulin A concentrations during the first year of lactation. Arch Dis Child 1998; 78:235-9.
15. Thomas JE, Dale A, Harding M, Weaver LT, Coward WA. Helicobacter pylori infection in early life in West Africa. Pediatr Res 1999; 45:218-23.
16. Rossi G, Ruggiero P, Pancotto L, et al. Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity and efficacy. Infect Immun 2004; 72:3252-9.
17. Parsonnet J, Shmuely H, Haggerty T. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA 1999; 282:2240-5.